Cerebral vascular effects of reactive oxygen species: Recent evidence for a role of NADPH-oxidase

Clinical and Experimental Pharmacology and Physiology

Volumn 30, Issue 11, 2003, Pages 855-859

  Paravicini, Tamara M ^a   Sobey, Christopher G ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Cerebral circulation; Free radicals; Hydrogen peroxide; Hypertension; NADPH oxidase; Reactive oxygen species; Subarachnoid haemorrhage; Superoxide; Superoxide dismutase; Vasodilatation

Indexed keywords

HYDROGEN PEROXIDE; OXYGEN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE;

ATHEROSCLEROSIS; BLOOD VESSEL TONE; BLOOD VESSEL WALL; BRAIN ARTERY; BRAIN CIRCULATION; BRAIN MICROCIRCULATION; CONFERENCE PAPER; HUMAN; HYPERTENSION; NONHUMAN; SUBARACHNOID HEMORRHAGE; VASODILATATION;

ANIMALS; CEREBROVASCULAR CIRCULATION; HUMANS; NADPH OXIDASE; REACTIVE OXYGEN SPECIES;

EID: 0345599152     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1681.2003.03920.x     Document Type: Conference Paper

References (39)

1. Griendling KK, Sorescu D. Lassegue B, Ushio-Fukai M. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler. Thromb. Vasc. Biol. 2000; 20: 2175-83.
2. Kunsch C, Medford RM. Oxidative stress as a regulator of gene expression in the vasculature. Circ. Res. 1999; 85: 753-66.
3. Wolin MS. Interactions of oxidants with vascular signaling systems. Arterioscler. Thromb. Vasc. Biol. 2000; 20: 1430-42.
4. Cheeseman KH, Slater TF. An introduction to free radical biochemistry. Br. Med. Bull. 1993; 49: 481-93.
5. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: The role of oxidant stress. Circ. Res. 2000; 87: 840-4.
6. Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase. Role in cardiovascular biology and disease. Circ. Res. 2000; 86: 494-501.
7. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and ugly. Am. J. Physiol. 1996; 271: C1424-37.
8. Harrison DG. Cellular and molecular mechanisms of endothelial cell dysfunction. J. Clin. Invest. 1997; 100: 2153-7.
9. Cosentino F, Sill JC, Katusic ZS. Role of superoxide anions in the mediation of endothelium-dependent contractions. Hypertension 1994; 23: 229-35.
10. Wei EP, Kontos HA, Beckman JS. Mechanisms of cerebral vasodilation by superoxide, hydrogen peroxide, and peroxynitrite. Am. J. Physiol. 1996; 271: H1262-6.
11. 2 effects on cerebral prostanoids and pial arteriolar diameter in piglets. Am. J. Physiol. 1990; 258: H1382-7.
12. 2 and endothelium-dependent cerebral arteriolar dilation. Implications for the identity of endothelium-derived relaxing factor generated by acetylcholine. Hypertension 1990; 16: 162-9.
13. Sobey CG, Heistad DD, Faraci FM. Potassium channels mediate dilatation of cerebral arterioles in response to arachidonate. Am. J. Physiol. 1998; 275: H1606-12.
14. + channels. Stroke 1997; 28: 2290-5.
15. Iida Y, Katusic ZS. Mechanisms of cerebral arterial relaxations to hydrogen peroxide. Stroke 2000; 31: 2224-30.
16. Babior BM. NADPH oxidase: An update. Blood 1999; 93: 1464-76.
17. Gorlach A, Brandes RP, Nguyen K, Amidi M, Dehghani F, Busse R. A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ. Res. 2000; 87: 26-32.
18. Pagano PJ, Clark JK, Cifuentes-Pagano ME, Clark SM, Callis GM, Quinn MT. Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: Enhancement by angiotensin II. Proc. Natl Acad. Sci. USA 1997; 94: 14483-8.
19. Lassegue B, Sorescu D, Szocs K et al. Novel gp91 (phox) homologues in vascular smooth muscle cells. Nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ. Res. 2001; 88: 888-94.
20. Suh YA, Arnold RS, Lassegue B et al. Cell transformation by the superoxide-generating oxidase Moxl. Nature 1999; 401: 79-82.
21. Sorescu D, Weiss D, Lassegue B et al. Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation 2002; 105: 1429-35.
22. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ. Res. 1994; 74: 1141-8.
23. Rajagopalan S, Kurz S, Munzel T et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J. Clin. Invest. 1996; 97: 1916-23.
24. De Keulenaer GW, Chappell DC, Ishizaka N, Nerem RM, Alexander RW, Griendling KK. Oscillatory and steady laminar shear stress differentially affect human endothelial redox state: Role of a superoxide-producing NADH oxidase. Circ. Res. 1998; 82: 1094-101.
25. Didion SP, Hathaway CA, Faraci FM. Superoxide levels and function of cerebral blood vessels after inhibition of CuZn-SOD. Am. J. Physiol. Heart Circ. Physiol 2001; 281: H1697-703.
26. Didion SP, Faraci FM. Effects of NADH and NADPH on superoxide levels and cerebral vascular tone. Am. J. Physiol. Heart Circ. Physiol. 2002; 282: H688-95.
27. Paravicini TM, Chrissobolis S, Drummond GR, Sobey CG. Activation of NADPH-oxidase induces cerebral vasodilatation that is enhanced in hypertension. In: Griendling KK, Krause K-H, Schmidt HHHW (eds). Proceedings of the 1st International Conference on NAD(P)H-Oxidases, 30 April-3 May 2002, Rauischholzhausen Castle, Germany. 2002; 70 (Abstract).
28. Didion SP, Ryan MJ, Didion LA, Fegan PE, Sigmund CD, Faraci FM. Increased superoxide and vascular dysfunction in CuZnSOD-deficient mice. Circ. Res. 2002; 91: 938-44.
29. Yang ST, Mayhan WG, Faraci FM, Heistad DD. Mechanisms of impaired endothelium-dependent cerebral vasodilatation in response to bradykinin in hypertensive rats. Stroke 1991; 22: 1177-82.
30. Paravicini TM, Gulluyan LM, Dusting GJ, Drummond GR. Increased NADPH oxidase activity, gp91phox expression, and endothelium-dependent vasorelaxation during neointima formation in rabbits. Circ. Res. 2002; 91: 54-61.
31. Souza HP, Souza LC, Anastacio VM et al. Vascular oxidant stress early after balloon injury: Evidence for increased NAD(P)H oxido-reductase activity. Free Radic. Biol. Med. 2000; 28: 1232-42.
32. Zalba G, Beaumont FJ, San Jose G et al. Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats. Hypertension 2000; 35: 1055-61.
33. Teunissen LL, Rinkel GJ, Algra A, van Gijn J. Risk factors for subarachnoid hemorrhage: A systematic review. Stroke 1996; 27: 544-9.
34. Sobey CG, Faraci FM. Subarachnoid haemorrhage: What happens to the cerebral arteries? Clin. Exp. Pharmacol. Physiol. 1998; 25: 867-76.
35. Australasian Cooperative Research on Subarachnoid Hemorrhage Study Group. Epidemiology of aneurysmal subarachnoid hemorrhage in Australia and New Zealand: Incidence and case fatality from the Australasian Cooperative Research on Subarachnoid Hemorrhage Study (ACROSS). Stroke 2000; 31: 1843-50.
36. Cook DA. Mechanisms of cerebral vasospasm in subarachnoid haemorrhage. Pharmacol. Ther. 1995; 66: 259-84.
37. Sato M, Tani E, Fujikawa H, Kaibuchi K. Involvement of Rho-kinase-mediated phosphorylation of myosin light chain in enhancement of cerebral vasospasm. Circ. Res. 2000; 87: 195-200.
38. Mori T, Nagata K, Town T, Tan J, Matsui T, Asano T. Intracisternal increase of superoxide anion production in a canine subarachnoid hemorrhage model. Stroke 2001; 32: 636-42.
39. Kim DE, Suh YS, Lee MS et al. Vascular NAD(P)H oxidase triggers delayed cerebral vasospasm after subarachnoid hemorrhage in rats. Stroke 2002; 33: 2687-91.